Knowledge Center

Driving Sustainable Progress in R&D

Laurent Petit - Head of Innovation and External Collaboration

As we approach the dawn of 2025, the intersection of Environmental, Social, and Governance (ESG) principles with innovation has never been more critical. Our company has been at the forefront of integrating ESG into our research and development (R&D) processes, setting ambitious goals and pioneering new methodologies to ensure sustainable progress. This article outlines our journey, key initiatives, and the impact of our efforts on the broader industry.

Read the article

Didier Combis - Marketing and Commercial development Head

Didier Combis of EUROAPI looks at why considering the API value chain can strengthen the global medicine supply chain.

Read the article

EUROAPI OPTIMIZES PHASE 3 PROCESS FOR SMALL MOLECULE PROJECT

The R&D Small Molecules Team in Frankfurt has successfully developed an efficient process to support a Phase 3 CDMO project with a smallsized company. The initial technical package included four steps and produced the API with a 52% overall yield and a PMI (Process Mass Intensity) of 159.

Read the case study

Advances in peptide synthesis with green chemistry and cutting-edge technologies

Read the poster

Recombinant Transaminase Case Study

From miniaturized scale to pilot plant (10m3 ): the Brindisi development approach

Read the white paper